You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Switched patients

Showing 1 - 25 of 2,705
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Onychomycosis of Fingernail Trial in Cairo (Topical tioconazole)

Recruiting
  • Onychomycosis of Fingernail
  • Topical tioconazole
  • Cairo, Egypt
    Kasr Alainy Faculty of Medicine
Aug 17, 2023

Dental Implant, Soft Tissue, Partial-edentulism Trial in Salamanca (Switched Prosthetic Profile, Matched Prosthetic Profile)

Recruiting
  • Dental Implant
  • +3 more
  • Switched Prosthetic Profile
  • Matched Prosthetic Profile
  • Salamanca, Spain
    Javier Montero
Dec 20, 2022

EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

Recruiting
  • Inflammatory Bowel Diseases
  • Rheumatologic Disease
  • Milano, Italy
    Irccs Ospedale San Raffaele
Jan 30, 2023

Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))

Not yet recruiting
  • Secondary Antibody Deficiency
  • Immunoglobulin replacement therapy (IGRT)
  • (no location specified)
Nov 4, 2022

A 24-month Real Life PErsistence Efficacy and Safety Study in

Recruiting
  • Inflammatory Bowel Diseases
  • Subcutaneous infliximab CT-P13 Remsima®SC
  • Grenoble, France
    Nicolas Mathieu
Aug 2, 2022

An Observational Clinical Study of the T3 Dental Implant System

Recruiting
  • Edentulous Jaw
  • T3 dental implant system
  • Gainesville, Florida
  • +2 more
Mar 24, 2022

Schizophrenia Trial (Lurasidone)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Jan 16, 2022

Psoriasis Trial in Jinan (regular treatment, Intensive treatment)

Not yet recruiting
  • Psoriasis
  • regular treatment
  • Intensive treatment
  • Jinan, Shandong, China
    Dermatology Hospital of Shandong First Medical University (Shand
Jul 24, 2023

Children, Teenagers and Severe Hemophilia A Who Switched From

Active, not recruiting
  • Hemophilia A
  • Non-Interventional
  • Hamilton, Ontario, Canada
    Hamilton-Niagara Regional Hemophilia Treatment Centre
Jan 16, 2023

Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam®

Withdrawn
  • Relapsing Remitting Multiple Sclerosis
  • monomethyl fumarate
  • (no location specified)
Nov 15, 2021

Schizophrenia Trial (SEP-363856)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Feb 22, 2023

Refractory Mixed Type Melasma Trial in New York (Q-Switched Nd:YAG Laser (RevLite), Retin-A and microdermabrasion)

Completed
Has Results
  • Refractory Mixed Type Melasma
  • Q-Switched Nd:YAG Laser (RevLite)
  • Retin-A and microdermabrasion
  • New York, New York
    New York Laser and Skin Care
Jan 5, 2022

Mechanical Ventilation on Lung Development of Alveolar Stage

Completed
  • Mechanical Ventilation
  • Abnormal Lung Development
  • Peak pressure when mechanical ventilation was switched around a reasonable range
  • Shanghai, Shanghai, China
    Department of Anesthesia, Shanghai Xinhua hospital
Aug 10, 2022

Renal Transplant Patients Trial in Aurora (Envarsus XR)

Completed
Has Results
  • Renal Transplant Patients
  • Envarsus XR
  • Aurora, Colorado
    Lisa Kornfeld
May 10, 2022

Children Who Have Switched to Isosource Junior Mix Formula

Completed
  • Cerebral Palsy
  • Isosource Junior Mix
  • Gatwick, United Kingdom
    Nestle Health Science
Aug 24, 2021

Myocardial Infarction Patients Who Were PrescribedNovel

Recruiting
  • Myocardial Infarction
    • Uijeongbu, Korea, Republic of
      The Catholic University of Korea, Uijeongbu ST. Mary's Hospital
    Oct 25, 2022

    Hyperpigmentation, Melasma, PRP Trial in Cairo (Q-switched nd:YAG laser toning)

    Recruiting
    • Hyperpigmentation
    • +3 more
    • Q-switched nd:YAG laser toning
    • Cairo, Egypt
      Department of Dermatology, Cairo University
    Feb 18, 2021

    Renal Transplant Trial in Nashville (Change from Prograf to Envarsus XR)

    Recruiting
    • Renal Transplant
    • Change from Prograf to Envarsus XR
    • Nashville, Tennessee
      VUMC
    Jul 8, 2021

    Keratosis, Seborrheic Trial (Hyfrecator, 532 nm Q-switched Nd:YAG laser)

    Withdrawn
    • Keratosis, Seborrheic
    • Hyfrecator
    • 532 nm Q-switched Nd:YAG laser
    • (no location specified)
    Dec 2, 2021

    Melasma Trial in Xi'an (tranexamic acid, 1064-nm Q-Switched fractional laser, 1064-nm Q-Switched laser)

    Completed
    • Melasma
    • tranexamic acid
    • +2 more
    • Xi'an, Shaanxi, China
      Dermatology Derpartment of Xijing Hospital
    Mar 10, 2021

    Acne Vulgaris Trial in United States (Adapalene Gel, 0.1%, Tazarotene Cream, 0.1%, Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%)

    Completed
    • Acne Vulgaris
    • Adapalene Gel, 0.1%
    • +2 more
    • San Diego, California
    • +11 more
    Jul 28, 2022

    Brain Injury Trial in West Orange (Sequential switched feedback training on the knee and the hip (Condition A), Feedback

    Recruiting
    • Brain Injury
    • Sequential switched feedback training on the knee and the hip (Condition A)
    • Feedback training on the knee alone (Condition B)
    • West Orange, New Jersey
      Kessler Foundation
    Mar 30, 2022

    Acanthosis Nigricans Trial (co2 laser)

    Not yet recruiting
    • Acanthosis Nigricans
    • co2 laser
    • (no location specified)
    May 18, 2021

    Lentigo Trial in Chicago (lidocaine 2.5%/prilocaine 2.5% topical anesthetic, lidocaine 7%/tetracaine 7% topical anesthetic,

    Active, not recruiting
    • Lentigo
    • lidocaine 2.5%/prilocaine 2.5% topical anesthetic
    • +3 more
    • Chicago, Illinois
      Northwestern University Feinberg School of Medicine, Department
    Mar 2, 2022

    XLH Trial in Japan, Korea, Republic of (KRN23)

    Completed
    • XLH
    • Sapporo, Hokkaido, Japan
    • +9 more
    Sep 1, 2022